International consensus guidelines on the management of cytomegalovirus in solid organ transplantation
- PMID: 20224515
- DOI: 10.1097/TP.0b013e3181cee42f
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation
Abstract
Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.
Comment in
-
Why valganciclovir should not be indicated for liver recipients and high-dose acyclovir should not be removed from international cytomegalovirus guidelines.Transplantation. 2011 Jan 15;91(1):e8-9; author reply e10. doi: 10.1097/TP.0b013e3181fc8921. Transplantation. 2011. PMID: 21441850 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
